Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry.

doi:10.1007/s12094-024-03511-7

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Dec 2024

Carcereny Enric, Rodriguez-Abreu Delvys, Lopez Rafael, Franco Fabio, Guirado Maria, Massutí Bartomeu, Cobo Manuel, Blasco Ana, Suay Guillermo, Del Barco Edel, Ortega Ana Laura, Sala Maria Angeles, Cordeiro Patricia, Bernabé Reyes, González Larriba José Luís, Bosch-Barrera Joaquim, Calzas Julia, Casal Joaquín, Padilla Airam, Sánchez-Hernandez Alfredo, Provencio Mariano

Abstract excerpt

BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for the vast majority of all diagnosed lung cancers. According to their histology, most NSCLCs are considered non-squamous cell carcinoma (NSCC), and up to 85% of the latter may lack either one of the two main actionable oncogenic drivers (i.e., EGFR mutations and ALK rearrangements). OBJECTIVE: Our analysis aimed to describe the clinical and epidemiological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to B7-H1 Antigen

Share to Carcinoma, Non-Small-Cell Lung

Share to Cross-Sectional Studies

Share to ErbB Receptors

Share to Progression-Free Survival

Share to Registries

Share to Spain

Source

Open in PubMed

Identifiers

PMID: 38862862
DOI: 10.1007/s12094-024-03511-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry.PMID 38862862Read ↗

Determination of essential biomarkers in lung cancer: a real-world data study in Spain.Semantic proximity Read ↗

Survival Outcomes of Metastatic Non-small Cell Lung Cancer Patients With Limited Access to Immunotherapy and Targeted Therapy in a Cancer Center of a Low- and Middle-Income Country.Semantic proximity Read ↗

Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017-2020.Semantic proximity Read ↗

Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026.Semantic proximity Read ↗

An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP).Semantic proximity Read ↗

Non-small cell lung cancer (NSCLC): characteristics, risk factors, molecular profile patterns, and treatment - a retrospective cohort study from Palestine.Semantic proximity Read ↗

Clinical characteristics of lung cancer in never-smokers: a multicenter Saudi cohort.Semantic proximity Read ↗

Epidemiological and clinical characteristics of lung cancer in Saudi Arabia: a retrospective study in single oncology center.Semantic proximity Read ↗

An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patientsSemantic proximity Read ↗

Real-World Survival Outcomes in Non-Small Cell Lung Cancer: The Impact of Genomic Testing and Targeted Therapies in a Latin American Middle-Income Country.Semantic proximity Read ↗

Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.Semantic proximity Read ↗

Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.